CIBMTR
@cibmtr.bsky.social
Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy.
Learn more at cibmtr.org.
Learn more at cibmtr.org.
CIBMTR's November Newsletter is now available! Read a message from our Advisory Committee Chair, about our new Immunobiology Working Committee Co-Scientific Director, a leadership transition for CIBMTR ACT, our new Page Scholars, and much more! Read online: cibmtr.org/CIBMTR/About...
November 3, 2025 at 4:36 PM
CIBMTR's November Newsletter is now available! Read a message from our Advisory Committee Chair, about our new Immunobiology Working Committee Co-Scientific Director, a leadership transition for CIBMTR ACT, our new Page Scholars, and much more! Read online: cibmtr.org/CIBMTR/About...
Senior Scientific Director of Patient-Centered Research and Survivorship, CIBMTR MCW, Dr. Rachel Cusatis, is now presenting at the CIBMTR Symposium at x.com/ISOQOL
October 24, 2025 at 9:51 PM
Senior Scientific Director of Patient-Centered Research and Survivorship, CIBMTR MCW, Dr. Rachel Cusatis, is now presenting at the CIBMTR Symposium at x.com/ISOQOL
CIBMTR’s patient-reported outcomes team presenting at the CIBMTR-sponsored symposium during this week’s ISOQOL conference!
October 24, 2025 at 4:43 PM
CIBMTR’s patient-reported outcomes team presenting at the CIBMTR-sponsored symposium during this week’s ISOQOL conference!
CIBMTR is proud to be attending and presenting at the 2025 ISOQOL Conference this week! Stay tuned for more information! Learn more, here: cibmtr.org/CIBMTR/About...
October 23, 2025 at 6:27 PM
CIBMTR is proud to be attending and presenting at the 2025 ISOQOL Conference this week! Stay tuned for more information! Learn more, here: cibmtr.org/CIBMTR/About...
Getting #BMT after an organ transplant may be risky, according to a recent CIBMTR study. Read more about the results of this study: cibmtr.org/Files/Patien...
October 20, 2025 at 3:28 PM
Getting #BMT after an organ transplant may be risky, according to a recent CIBMTR study. Read more about the results of this study: cibmtr.org/Files/Patien...
Registration for #Tandem26 is officially open! Don’t miss the opportunity to join us in Salt Lake City in February 2026. Reserve your spot today! Learn more and register today: www.tandemmeetings.com/.../Registra...
October 17, 2025 at 8:34 PM
Registration for #Tandem26 is officially open! Don’t miss the opportunity to join us in Salt Lake City in February 2026. Reserve your spot today! Learn more and register today: www.tandemmeetings.com/.../Registra...
CIBMTR and the MCW Division of Hematology and Oncology invite applications for a faculty position as a CIBMTR Scientific Director. Learn more about and apply for this important position: careers.peopleclick.com/careerscp/cl...
October 7, 2025 at 7:55 PM
CIBMTR and the MCW Division of Hematology and Oncology invite applications for a faculty position as a CIBMTR Scientific Director. Learn more about and apply for this important position: careers.peopleclick.com/careerscp/cl...
For patients unlikely to have a fully matched donor, their team should quickly switch to searching for alternate (mismatched) donors. Read more about this BMT CTN study just published in the Journal of Clinical Oncology: cibmtr.org/Files/Patien...
September 19, 2025 at 3:52 PM
For patients unlikely to have a fully matched donor, their team should quickly switch to searching for alternate (mismatched) donors. Read more about this BMT CTN study just published in the Journal of Clinical Oncology: cibmtr.org/Files/Patien...
Just over a month until ISOQOL 2025! A symposium will feature CIBMTR, highlighting the integration of PROs into clinical registries for HCT and cellular therapy, including HCT and CAR-T. Learn more: cibmtr.org/CIBMTR/About...
September 10, 2025 at 7:57 PM
Just over a month until ISOQOL 2025! A symposium will feature CIBMTR, highlighting the integration of PROs into clinical registries for HCT and cellular therapy, including HCT and CAR-T. Learn more: cibmtr.org/CIBMTR/About...
Abstract submission for #Tandem26 is now open! ASTCT and CIBMTR invite you to share your research with 5,000+ HCT, cell, and gene therapy colleagues in Salt Lake City, UT, February 4-7, 2026! Learn more and submit an abstract at www.tandemmeetings.com/Abstracts/Ab...
August 26, 2025 at 6:42 PM
Abstract submission for #Tandem26 is now open! ASTCT and CIBMTR invite you to share your research with 5,000+ HCT, cell, and gene therapy colleagues in Salt Lake City, UT, February 4-7, 2026! Learn more and submit an abstract at www.tandemmeetings.com/Abstracts/Ab...
There is not much data about what happens to patients who don’t have a caregiver after transplant. But most doctors won’t provide #BMT to patients who don’t have a caregiver. Experts say that should change. Read more: cibmtr.org/Files/Patien...
August 19, 2025 at 8:58 PM
There is not much data about what happens to patients who don’t have a caregiver after transplant. But most doctors won’t provide #BMT to patients who don’t have a caregiver. Experts say that should change. Read more: cibmtr.org/Files/Patien...
According to a recent study, nearly 100% of people said that it’s very important that researchers ask patients directly about their quality of life. Read more: cibmtr.org/Files/Patien...
August 12, 2025 at 8:34 PM
According to a recent study, nearly 100% of people said that it’s very important that researchers ask patients directly about their quality of life. Read more: cibmtr.org/Files/Patien...
Attending #ISOQOL 2025 this fall? A symposium will feature CIBMTR, highlighting the integration of PROs into clinical registries for HCT and cellular therapy, including HCT and CAR-T. Learn more: cibmtr.org/CIBMTR/About...
August 12, 2025 at 3:07 PM
Attending #ISOQOL 2025 this fall? A symposium will feature CIBMTR, highlighting the integration of PROs into clinical registries for HCT and cellular therapy, including HCT and CAR-T. Learn more: cibmtr.org/CIBMTR/About...
CIBMTR's August Newsletter is now available! Read about two new Scientific Directors, a PRO Protocol milestone, our newest Page Scholars, our CRO Services, and much more! Read online: cibmtr.org/CIBMTR/About...
August 1, 2025 at 3:19 PM
CIBMTR's August Newsletter is now available! Read about two new Scientific Directors, a PRO Protocol milestone, our newest Page Scholars, our CRO Services, and much more! Read online: cibmtr.org/CIBMTR/About...
New CIBMTR Scientific Director: Wasay Khan, MD, to serve as Scientific Director for Clinical Informatics. Read more about this exciting announcement: cibmtr.org/CIBMTR/About...
July 28, 2025 at 2:11 PM
New CIBMTR Scientific Director: Wasay Khan, MD, to serve as Scientific Director for Clinical Informatics. Read more about this exciting announcement: cibmtr.org/CIBMTR/About...
Health Care Providers: Have you ever wondered about the effects of CAR T-cells on your patients' #fertility? Help The Leukemia & Lymphoma Society gather critical information by referring patients to this survey: form.typeform.com/to/rGw4Udaj
July 25, 2025 at 5:33 PM
Health Care Providers: Have you ever wondered about the effects of CAR T-cells on your patients' #fertility? Help The Leukemia & Lymphoma Society gather critical information by referring patients to this survey: form.typeform.com/to/rGw4Udaj
We welcome our newest Page Scholars and congratulate our inaugural group of scholars! Read more about these two wonderful groups: cibmtr.org/CIBMTR/About...
July 16, 2025 at 9:00 PM
We welcome our newest Page Scholars and congratulate our inaugural group of scholars! Read more about these two wonderful groups: cibmtr.org/CIBMTR/About...
After a partially matched transplant, #GVHD can result. Previously, partially matched donors caused more GVHD than fully matched donors in cancer patients. A new approach, using cyclophosphamide, can prevent most GVHD. Read more: cibmtr.org/Files/Patien...
July 1, 2025 at 4:32 PM
After a partially matched transplant, #GVHD can result. Previously, partially matched donors caused more GVHD than fully matched donors in cancer patients. A new approach, using cyclophosphamide, can prevent most GVHD. Read more: cibmtr.org/Files/Patien...
New CIBMTR Scientific Director: Najla El Jurdi, MD, to serve as Scientific Director of Graft-versus-Host Disease Working Committee. Read more about this exciting announcement: cibmtr.org/CIBMTR/About...
June 26, 2025 at 9:09 PM
New CIBMTR Scientific Director: Najla El Jurdi, MD, to serve as Scientific Director of Graft-versus-Host Disease Working Committee. Read more about this exciting announcement: cibmtr.org/CIBMTR/About...
In the past, people with sickle cell disease could only get #BMT if they had a fully matched donor, but with newer medicines, people can get BMT from a half-matched donor, like a parent or sibling. Read more about this BMT CTN study: cibmtr.org/Files/Patien...
June 12, 2025 at 7:27 PM
In the past, people with sickle cell disease could only get #BMT if they had a fully matched donor, but with newer medicines, people can get BMT from a half-matched donor, like a parent or sibling. Read more about this BMT CTN study: cibmtr.org/Files/Patien...
A small BMT CTN study showed that #BMT is one good option for treating sickle cell disease in teens and young adults. Learn more about this study: cibmtr.org/Files/Patien...
June 9, 2025 at 8:00 PM
A small BMT CTN study showed that #BMT is one good option for treating sickle cell disease in teens and young adults. Learn more about this study: cibmtr.org/Files/Patien...
CIBMTR is excited to announce we reached a major milestone on the CIBMTR PRO Protocol! More than 5,000 patient-reported outcomes (#PRO) surveys have now been collected from 1,700+ patients across 43 centers. Read more: cibmtr.org/CIBMTR/About...
June 2, 2025 at 7:59 PM
CIBMTR is excited to announce we reached a major milestone on the CIBMTR PRO Protocol! More than 5,000 patient-reported outcomes (#PRO) surveys have now been collected from 1,700+ patients across 43 centers. Read more: cibmtr.org/CIBMTR/About...
CIBMTR's May Newsletter is now available! Read a message from our Advisory Committee Chair, a tribute to a leader in our field, about how to access our latest Summary Slides, about two of our working committees, and more. Read online: cibmtr.org/CIBMTR/About...
May 1, 2025 at 4:55 PM
CIBMTR's May Newsletter is now available! Read a message from our Advisory Committee Chair, a tribute to a leader in our field, about how to access our latest Summary Slides, about two of our working committees, and more. Read online: cibmtr.org/CIBMTR/About...
NOW AVAILABLE: 2024 CIBMTR Summary Slides. These slides provide an annual report on data submitted by US centers to CIBMTR, detailing practices and general survival outcomes following cellular therapies. Learn more: cibmtr.org/CIBMTR/Resou...
April 28, 2025 at 7:33 PM
NOW AVAILABLE: 2024 CIBMTR Summary Slides. These slides provide an annual report on data submitted by US centers to CIBMTR, detailing practices and general survival outcomes following cellular therapies. Learn more: cibmtr.org/CIBMTR/Resou...
Results of a new BMT CTN study show that patients who got cyclophosphamide lived longer without CGVHD, compared to patients who got other medicines. Read more: cibmtr.org/Files/Patien...
April 23, 2025 at 8:20 PM
Results of a new BMT CTN study show that patients who got cyclophosphamide lived longer without CGVHD, compared to patients who got other medicines. Read more: cibmtr.org/Files/Patien...